PLATINUM Diversity
- Conditions
- AtherosclerosisCoronary Artery Disease
- Interventions
- Device: Percutaneous coronary intervention (Promus PREMIER)
- Registration Number
- NCT02240810
- Lead Sponsor
- Boston Scientific Corporation
- Brief Summary
To compile acute procedural performance and clinical outcomes data for the Promus PREMIER everolimus-eluting coronary stent system in understudied/underserved patient populations including women and minorities.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1501
-
Patient must be at least 18 years of age
-
Patient must sign informed consent form
-
Patient has received at least one Promus PREMIER stent
-
Patient self-identifies as one or more of the following:
- Female
- Black of African Heritage
- Hispanic/Latino
- American Indian or Alaska native
- Not applicable
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description PLATINUM Diversity (Overall) Percutaneous coronary intervention (Promus PREMIER) PLATINUM Diversity (Overall) population. Test device is Promus PREMIER Everolimus-Eluting Platinum Chromium Coronary Stent System (CSS)
- Primary Outcome Measures
Name Time Method Composite Rate of Death, Myocardial Infarction (MI), and Target Vessel Revascularization (TVR) Participants will be followed for the duration of hospital stay, an expected average of 1 day, through 12 months A Clinical Events Committee (CEC), independent group of physician experts was used to evaluate all reported cases of death, MI, TVR to determine whether they met the specific protocol definition of the event. It is the CEC adjudicated result that is used in the endpoint analysis. Results for the PROMUS Element Plus study are reported in record NCT01589978
- Secondary Outcome Measures
Name Time Method Death Participants will be followed for the duration of hospital stay, an expected average of 1 day, through 12 months A Clinical Events Committee (CEC), independent group of physician experts was used to evaluate all reported cases of death to determine whether they met the specific protocol definition of the event. It is the CEC adjudicated result that is used in the endpoint analysis. Results for the PROMUS Element Plus study are reported in record NCT01589978
Target Vessel Revascularization (TVR) Participants will be followed for the duration of hospital stay, an expected average of 1 day, through 12 months A Clinical Events Committee (CEC), independent group of physician experts was used to evaluate all reported cases of TVR to determine whether they met the specific protocol definition of the event. It is the CEC adjudicated result that is used in the endpoint analysis. Results for the PROMUS Element Plus study are reported in record NCT01589978
Myocardial Infarction (MI) Participants will be followed for the duration of hospital stay, an expected average of 1 day, through 12 months A Clinical Events Committee (CEC), independent group of physician experts was used to evaluate all reported cases of MI to determine whether they met the specific protocol definition of the event. It is the CEC adjudicated result that is used in the endpoint analysis. Results for the PROMUS Element Plus study are reported in record NCT01589978
Trial Locations
- Locations (52)
St Luke's Medical Center
🇺🇸Phoenix, Arizona, United States
St Bernards Heart and Vascular
🇺🇸Jonesboro, Arkansas, United States
Arkansas Cardiology/Baptist Health Medical Center
🇺🇸Little Rock, Arkansas, United States
Central Cardiology Medical Clinic
🇺🇸Bakersfield, California, United States
Sharp Chula Vista Medical Center
🇺🇸Chula Vista, California, United States
Cardiovascular Consultants Heart Center
🇺🇸Fresno, California, United States
UCLA Medical Center
🇺🇸Los Angeles, California, United States
Mercy General Hospital
🇺🇸Sacramento, California, United States
Capital Research Institute
🇺🇸Washington, District of Columbia, United States
Bay Area Cardiology
🇺🇸Brandon, Florida, United States
Scroll for more (42 remaining)St Luke's Medical Center🇺🇸Phoenix, Arizona, United States